CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-05-02 | Labrucherie Gil M SVP & Chief Financial Officer | Exercise or conversion | +30,000 | $10.69 | $321K | 129,739 |
| 2018-05-02 | Labrucherie Gil M SVP & Chief Financial Officer | Sale | −30,000 | $85.63 | $2.6M | 99,739 |
| 2018-05-02 | Labrucherie Gil M SVP & Chief Financial Officer | Exercise or conversion · Stock Option | −30,000 | 30,000 | ||
| 2018-05-02 | ROBIN HOWARD W President & CEO | Exercise or conversion | +43,333 | $10.69 | $463K | 280,480 |
| 2018-05-02 | ROBIN HOWARD W President & CEO | Sale | −43,333 | $85.63 | $3.7M | 237,147 |
| 2018-05-02 | ROBIN HOWARD W President & CEO | Exercise or conversion · Stock Option | −43,333 | 213,333 | ||
| 2018-05-01 | Labrucherie Gil M SVP & Chief Financial Officer | Exercise or conversion | +30,000 | $10.69 | $321K | 129,739 |
| 2018-05-01 | Labrucherie Gil M SVP & Chief Financial Officer | Sale | −30,000 | $83.65 | $2.5M | 99,739 |
| 2018-05-01 | Labrucherie Gil M SVP & Chief Financial Officer | Exercise or conversion · Stock Option | −30,000 | 60,000 | ||
| 2018-05-01 | ROBIN HOWARD W President & CEO | Exercise or conversion | +43,334 | $10.69 | $463K | 280,481 |
| 2018-05-01 | ROBIN HOWARD W President & CEO | Sale | −43,334 | $83.65 | $3.6M | 237,147 |
| 2018-05-01 | ROBIN HOWARD W President & CEO | Exercise or conversion · Stock Option | −43,334 | 256,666 | ||
| 2018-04-17 | WHITFIELD ROY A Director | Exercise or conversion | +30,000 | $14.26 | $428K | 172,000 |
| 2018-04-17 | WHITFIELD ROY A Director | Exercise or conversion · Stock Option | −30,000 | 0 | ||
| 2018-04-16 | Thomsen Jillian B. SVP & Chief Accounting Officer | Exercise or conversion | +13,881 | $10.69 | $148K | 82,738 |
| 2018-04-16 | Thomsen Jillian B. SVP & Chief Accounting Officer | Sale | −13,881 | $101.46 | $1.4M | 68,857 |
| 2018-04-16 | Thomsen Jillian B. SVP & Chief Accounting Officer | Exercise or conversion · Stock Option | −13,881 | 16,119 | ||
| 2018-04-10 | Hora Maninder SVP Pharma Dev & Mfg Ops | Exercise or conversion | +502 | $7.21 | $4K | 80,763 |
| 2018-04-10 | Hora Maninder SVP Pharma Dev & Mfg Ops | Sale | −502 | $105.67 | $53K | 80,261 |
| 2018-04-10 | Hora Maninder SVP Pharma Dev & Mfg Ops | Exercise or conversion · Stock Option | −502 | 32,500 |
Page 33 of 43 · 847 trades